Concepedia

Author

Le Zhang

Tianjin Medical University Cancer Institute and HospitalORCID

Also Known As

Bo Xiao, Le Zhang, Zhang Le, Zhang, Le

114

Publications

2K

Citations

22

H-Index

64

Concepts

All Affiliations

Tianjin Medical University Cancer Institute and HospitalSun Yat-sen University Cancer CenterSun Yat-sen UniversityGannan Medical UniversityXiangya Hospital Central South University
LZ

About

Le Zhang is an author at Tianjin Medical University Cancer Institute and Hospital specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

13

783

2

Health Sciences

2

2

110

3

Natural Sciences

1

1

23

4

Public Health

1

1

16

5

Social Sciences

1

1

30

Le Zhang

×

29

Publications

1.3K

Citations

21

H-Index

YearCitations

Metformin treatment prevents amyloid plaque deposition and memory impairment in APP/PS1 mice

Zhenri Ou, Xuejian Kong, Xiangdong Sun,

Brain Behavior and Immunity

2017

349

Incidence of Cerebral Hemorrhage in the Changsha Community

Qidong Yang, Qi Niu, Yanhong Zhou,

Cerebrovascular Diseases

2004

98

c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia

Bing Xia, Chen Tian, Shanqi Guo,

Leukemia Research

2014

82

Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma

Yuchong Yang, Xuanzhang Huang, Likun Zhou,

BMC Cancer

2019

65

Onco-miR-130 promotes cell proliferation and migration by targeting TGFβR2 in gastric cancer

Jingjing Duan, Haiyang Zhang, Yanjun Qu,

Oncotarget

2016

59

Triplet combination with paclitaxel, cisplatin and 5-FU is effective in metastatic and/or recurrent nasopharyngeal carcinoma

Cui Chen, Feng-Hua Wang, Xin An,

Cancer Chemotherapy and Pharmacology

2012

50

Are Risk Factors Associated with Outcomes in Pancreatic Cancer?

De‐Shen Wang, Zhi-qiang Wang, Le Zhang,

PLoS ONE

2012

45

Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.

Xu Guan, Fang Zhao, Jing Ya Wang,

PubMed

2017

44

The efficacy and safety of modified FOLFIRINOX as first‐line chemotherapy for Chinese patients with metastatic pancreatic cancer

Zhi‐Qiang Wang, Fei Zhang, Ting Deng,

Cancer Communications

2019

43

Phase II study of perioperative toripalimab in combination with FLOT in patients with locally advanced resectable gastric/gastroesophageal junction (GEJ) adenocarcinoma.

Hongli Li, Jingyu Deng, Shaohua Ge,

Journal of Clinical Oncology

2021

34

Page 1